These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9303376)

  • 1. Physical characteristics and lipoprotein distribution of liposomal nystatin in human plasma.
    Wasan KM; Ramaswamy M; Cassidy SM; Kazemi M; Strobel FW; Thies RL
    Antimicrob Agents Chemother; 1997 Sep; 41(9):1871-5. PubMed ID: 9303376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Species differences in the proportion of plasma lipoprotein lipid carried by high-density lipoproteins influence the distribution of free and liposomal nystatin in human, dog, and rat plasma.
    Ramaswamy M; Wallace TL; Cossum PA; Wasan KM
    Antimicrob Agents Chemother; 1999 Jun; 43(6):1424-8. PubMed ID: 10348764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma lipoprotein distribution of liposomal nystatin is influenced by protein content of high-density lipoproteins.
    Cassidy SM; Strobel FW; Wasan KM
    Antimicrob Agents Chemother; 1998 Aug; 42(8):1878-88. PubMed ID: 9687378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferential distribution of amphotericin B lipid complex into human HDL3 is a consequence of high density lipoprotein coat lipid content.
    Kennedy AL; Wasan KM
    J Pharm Sci; 1999 Nov; 88(11):1149-55. PubMed ID: 10564063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modifications in high-density lipoprotein lipid composition and structure alter the plasma distribution of free and liposomal annamycin.
    Wasan KM; Ng S; Cassidy SM
    J Pharm Sci; 1997 Jul; 86(7):872-5. PubMed ID: 9232531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in lipoprotein lipid concentration and composition modify the plasma distribution of cyclosporine.
    Wasan KM; Pritchard PH; Ramaswamy M; Wong W; Donnachie EM; Brunner LJ
    Pharm Res; 1997 Nov; 14(11):1613-20. PubMed ID: 9434283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in lipoprotein concentration and composition modify the plasma distribution of free and liposomal annamycin.
    Wasan KM; Morton RE
    Pharm Res; 1996 Mar; 13(3):462-8. PubMed ID: 8692743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in the lipoprotein distribution of halofantrine are regulated by lipoprotein apolar lipid and protein concentration and lipid transfer protein I activity: in vitro studies in normolipidemic and dyslipidemic human plasmas.
    Wasan KM; Ramaswamy M; McIntosh MP; Porter CJ; Charman WN
    J Pharm Sci; 1999 Feb; 88(2):185-90. PubMed ID: 9950636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diversity of lipid-based polyene formulations and their behavior in biological systems.
    Wasan KM; Lopez-Berestein G
    Eur J Clin Microbiol Infect Dis; 1997 Jan; 16(1):81-92. PubMed ID: 9063678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of liposome composition and temperature in distribution of amphotericin B in serum lipoproteins.
    Wasan KM; Brazeau GA; Keyhani A; Hayman AC; Lopez-Berestein G
    Antimicrob Agents Chemother; 1993 Feb; 37(2):246-50. PubMed ID: 8452354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporine A transfer between high- and low-density lipoproteins: independent from lipid transfer protein I-facilitated transfer of lipoprotein-coated phospholipids because of high affinity of cyclosporine a for the protein component of lipoproteins.
    Kwong M; Sivak O; Kwong EH; Wasan KM
    J Pharm Sci; 2001 Sep; 90(9):1308-17. PubMed ID: 11745783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of phospholipid transfer protein on the plasma distribution of amphotericin B following the incubation of different amphotericin B formulations.
    Patankar N; Wasan KM
    Pharm Res; 2006 May; 23(5):1020-4. PubMed ID: 16715392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human plasma distribution of free paclitaxel and paclitaxel associated with diblock copolymers.
    Ramaswamy M; Zhang X; Burt HM; Wasan KM
    J Pharm Sci; 1997 Apr; 86(4):460-4. PubMed ID: 9109049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma protein binding, lipoprotein distribution and uptake of free and lipid-associated BCL-2 antisense oligodeoxynucleotides (G3139) in human melanoma cells.
    Wasan EK; Waterhouse D; Sivak O; Bally MB; Klasa RJ; Wasan KM
    Int J Pharm; 2002 Jul; 241(1):57-64. PubMed ID: 12086721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of step-gradient and sequential density ultracentrifugation and the use of lipoprotein deficient plasma controls in determining the plasma lipoprotein distribution of lipid-associated nystatin and cyclosporine.
    Wasan KM; Cassidy SM; Ramaswamy M; Kennedy A; Strobel FW; Ng SP; Lee TY
    Pharm Res; 1999 Jan; 16(1):165-9. PubMed ID: 9950297
    [No Abstract]   [Full Text] [Related]  

  • 16. Differences in the lipoprotein distribution of free and liposome-associated all-trans-retinoic acid in human, dog, and rat plasma are due to variations in lipoprotein lipid and protein content.
    Wasan KM; Ramaswamy M; Ng SP; Wong W; Parrott SC; Ojwang JO; Wallace T; Cossum PA
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1646-53. PubMed ID: 9660998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood and plasma lipoprotein distribution and gender differences in the plasma pharmacokinetics of lipid-associated annamycin.
    Wasan KM; Kwong M
    Pharmacol Toxicol; 1997 Jun; 80(6):301-7. PubMed ID: 9225368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The in vitro plasma distribution of a novel cholesteryl ester transfer protein inhibitor, torcetrapib, is influenced by differences in plasma lipid concentrations.
    Lee SD; Wasan KM; Calcagni A; Avery M; McCush F; Chen C
    Pharm Res; 2006 May; 23(5):1025-30. PubMed ID: 16715393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicity and therapeutic effects in mice of liposome-encapsulated nystatin for systemic fungal infections.
    Mehta RT; Hopfer RL; McQueen T; Juliano RL; Lopez-Berestein G
    Antimicrob Agents Chemother; 1987 Dec; 31(12):1901-3. PubMed ID: 3439799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modifications in lipoprotein surface charge alter cyclosporine A association with low-density lipoproteins.
    Wasan KM; Sivak O
    Pharm Res; 2003 Jan; 20(1):126-9. PubMed ID: 12608546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.